Knipper Health, Inc., the leading provider of end-to-end pharmaceutical healthcare marketing services in the U.S. for the biopharmaceutical and medical industries, has announced the acquisition of Patheon Pharma Services’ sample and fulfillment operations from Thermo Fisher Scientific, based in Memphis, TN. As part of the transition, Knipper will retain all employees, the Memphis facility, and existing customers. Both Knipper Health and Thermo Fisher are working closely to ensure a smooth and seamless transition for everyone involved.
Knipper Health, Inc., a leading provider of marketing and sample management solutions for the life sciences industry, has announced the acquisition of Patheon Pharma Services’ sample and fulfillment operations from Thermo Fisher Scientific. This move underscores Knipper Health’s continued commitment to expanding its capabilities to meet the growing demands of its customers. The Memphis, TN facility, which will now be part of Knipper Health’s operations, will help enhance the company’s cold chain capabilities, joining existing facilities in Lakewood, NJ, and Charlestown, IN. With the Memphis facility’s proximity to the FedEx world hub, Knipper Health is also positioned to speed up delivery services across the country.
Michael Laferrera, CEO of Knipper Health, expressed his enthusiasm about the acquisition: “As the leading supplier of marketing and sample management solutions to the life sciences industry, this assignment further demonstrates Knipper Health’s commitment to investing in and expanding our capabilities to serve the growing needs of our customers. The addition of the Memphis facility will strengthen our cold chain footprint and position us for future growth. Moreover, its location near the FedEx world hub will allow us to accelerate deliveries nationwide.”
Laferrera further emphasized the company’s customer-centric approach: “We continuously put the needs of our customers at the forefront and are excited that our commercial sample customers, as well as our employees, will now be in the dedicated hands of the Knipper Health organization.”
This strategic decision is not only about growth but also a shared commitment to improving service quality and operational efficiency. The transition process will begin immediately, with full integration expected to be completed by September 2025. Both Knipper Health and Thermo Fisher are working closely to ensure a smooth, seamless transition for all customers and employees during this period.
Molly Flick, Vice President of BioServices and Specialty Logistics at Thermo Fisher Scientific, also shared her optimism about the acquisition: “We believe that the business will benefit from Knipper Health’s experience and their dedication to partnering with clients. Their focus on creating the shortest path between the patient and therapy aligns perfectly with the needs of the business.”
Founded more than 35 years ago, Knipper Health is a leading healthcare solutions company providing tailored services to the pharmaceutical, biotechnology, and medical device industries. Their services cover a wide range of areas, including sample fulfillment and distribution, direct marketing, data services, sample compliance, third-party logistics, and custom pharmacy solutions. Knipper Health offers end-to-end, bespoke solutions that address clients’ unique needs, regardless of scope or complexity.
This acquisition marks a significant step for Knipper Health as it continues to expand its operational footprint and strengthen its position as a leader in the healthcare marketing and sample management space.
